Th1/Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: A pilot study in HIV-positive individuals with oropharyngeal candidiasis

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 19, Issue 4, 1998, Pages 373-380

  Leigh, Janet E ^a   Steele, Chad ^b   Wormley Jr , Floyd L ^b   Luo, Wei ^b   Clark, Rebecca A ^b   Gallaher, William ^b   Fidel Jr , Paul L ^b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF DENTISTRY   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Candida albicans; Candidiasis; Cytokines; HIV; Oral mucosa; Th1 Th2

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4;

ADULT; AIDS RELATED COMPLEX; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELLULAR IMMUNITY; CLINICAL ARTICLE; CYTOKINE RESPONSIVE ELEMENT; FEMALE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; MOUTH MUCOSA; OPPORTUNISTIC INFECTION; OROPHARYNX; PILOT STUDY; PRIORITY JOURNAL; PROTEIN STABILITY; SALIVA ANALYSIS; T LYMPHOCYTE SUBPOPULATION;

EID: 0032402291     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199812010-00008     Document Type: Article

References (43)

1. Clerici M, Shearer GM. A TH1-TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-11.
2. Clerici M, Fusi ML, Ruzzante S, et al. Type 1 and type 2 cytokines in HIV infection - a possible role in apoptosis and disease progression. Ann Med 1997;29:185-8.
3. Shearer GM, Clerici M. T helper cell immune dysfunction in asymptomatic, HIV-1-seropositive individuals: the role of TH1-TH2 cross-regulation. Cell Immunol 1992;54:21-43.
4. Graziosi C, Pantaleo G, Ganett KR, Demarest JF, Cohen OJ, Fauci AS. Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Science 1994;265:248-52.
5. Hu R, Oyaizu N, Kalyanaraman VS, Pahwa S, HIV-1 gp160 as a modifier of Th1 and Th2 cytokine response: gp160 suppresses interferon-gamma and interleukin-2 production concomitantly with enhanced interleukin-4 production in vitro. Clin Immunol Immunopathol 1994;73:245-51.
6. Barcellini W, Rizzardi GP, Borghi MO, Fain C, Lazzarin A, Meroni PL. Th1 and Th2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS 1994;8:757-62.
7. Landay AL, Clerici M, Hashemi F, Kessler H, Berzofsky JA, Shearer GM. In vitro restoration of T cell immune function in human immunodeficiency virus-positive persons: effects of interleukin (IL)-12 and anti-IL-10. J Infect Dis 1996;173:1085-91.
8. Maggi E, Romagnani S. Th1 versus Th2 responses in AIDS. Curr Opin Immunol 1994;4:616-22.
9. Maggi E, Mazzetti M, Ravina A, et al. Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 1994;265:244-8.
10. Sha BE, D'Amico RD, Landay AL, et al. Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:161-8.
11. Lamster IB, Begg MD, Mitchell-Lewis D, et al. Oral manifestations of HIV infection in homosexual men and intravenous drug users. Oral Surg Oral Med Oral Pathol 1994;78:163-74.
12. Shiboski CH, Hilton JF, Greenspan D, et al. HIV-related oral manifestations in two cohorts of women in San Francisco. J Acquir Immune Defic Syndr 1994;7:964-71.
13. Samaranayake LP. Oral mycoses in HIV infection. Oral Surg Oral Med Oral Pathol 1992;73:171-80.
14. Hauman CH, Thompson IO, Theunissen F, Wolfaart P. Oral carriage of Candida in healthy and HIV-seropositive persons. Oral Surg Oral Med Oral Pathol 1993;76:570-2.
15. Klein RS, Harris CA, Small CB, et al. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984;311:354-7.
16. Macher AM. The pathology of AIDS. Public Health Rep 1988; 103:246-50.
17. Clift RA. Candidiasis in the transplant patient. Am J Med 1984;77(Suppl 4D):34-8.
18. Knight L, Fletcher J. Growth of Candida albicans in saliva: stimulation by glucose associated with antibiotics, corticosteroids and diabetes mellitus. J Infect Dis 1971;123:371-7.
19. Imam N, Carpenter CCJ, Mayer KH, Fisher A, Stein M, Danforth SB. Hierarchical pattern of mucosal Candida infections in HIV-seropositive women. Am J Med 1990;89:142-6.
20. Odds FC. Candida and candidosis. Baltimore, MD: University Park Press, 1988:104-10.
21. Fischer A, Ballet JJ, Griscelli C. Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharide antigens present in serum of patients with chronic mucocutaneous candidiasis. J Clin Invest 1978;62:1005-13.
22. Paterson PY, Semo R, Blumenschein G, Swelstad J. Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy. Clin Exp Immunol 1971;9:595-602.
23. Romani L, Mocci S, Bietta C, Lanfaloni L, Puccetti P, Bistoni F. Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect Immunol 1991;59:4647-54.
24. Puccetti P, Romani L, Bistoni F. A Th1-Th2-like switch in candidiasis: new perspectives for therapy. Trends Microbiol 1995;3: 237-40.
25. Mosman TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989;7:145-73.
26. Scott P, Kaufmann SHE. The role of T-cell subsets and cytokines in the regulation of infection. Immunol Today 1991;12:346-8.
27. Odden K, Schenck K, Hurlen B. High numbers of T cells in gingiva from patients with human immunodeficiency virus (HIV) infection. J Oral Pathol Med 1995;24:413-9.
28. Steidley KE, Thompson SH, McQuade MJ, Strong SL, Scheidt MJ, Van Dyle TE. A comparison of T4:T8 lymphocyte ratio in the periodontal lesion of healthy and HIV-positive patients. J Periodontol 1992;63:753-6.
29. + lymphocytes in chronic gingivitis from HIV-positive patients: a pilot study. J Periodontol 1997;68:881-3.
30. Yamamoto M, Fujihashi K, Hiroi T, McGhee JR, Van Dyke TE, Kiyono H. Molecular and cellular mechanisms for periodontal diseases: role of Th 1 and Th2 type cytokines in induction of mucosal inflammation. J Periodontal Res 1997;32:115-9.
31. + gingival lymphocytes supports migration of activated memory T lymphocytes to diseased periodontal tissue. Oral Microbiol Immunol 1997;12:129-34.
32. Fidel PL Jr, Lynch ME, Redondo-Lopez V, Sobel JD, Robinson R. Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis (RVVC). J Infect Dis 1993;168: 1458-65.
33. Klein SA, Dobmeyer JM, Dobmeyer TS, et al. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS 1997;11:1111-8.
34. Fidel PL Jr, Ginsburg KA, Cutright JL, et al. Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen. J Infect Dis 1997;176:728-39.
35. Fox RI, Kang HI, Ando D, Abrams J, Pisa E. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol 1994;152:5532-9.
36. Belec L, Gherardi R, Payan C, et al. Proinflammatory cytokine expression in cervicovaginal secretions of normal and HIV-infected women. Cytokine 1995;7:568-74.
37. Coogan MM, Sweet SP, Challacombe SJ. Immunoglobulin A (IgA), IgAl, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS. Infect Immunol 1994;62:892-6.
38. Sweet SP, Chaliacombe SJ, Naglik JR. Whole and parotid saliva IgA and IgA-subclass responses to Candida albicans in HIV infection. Adv Exp Med Biol 1995;371(B):1031-4.
39. Fidel PL Jr, Lynch ME, Conaway DH, Tait L, Sobel JD. Mice immunized by primary vaginal C. albicans infection develop acquired vaginal mucosal immunity. Infect Immunol 1995;63:547-53.
40. Fidel PL Jr, Wolf NA, Cutright JL, et al. Candida-specific Th1/ Th2 reactivity in HIV+- women [abstract]. Presented at the American Society for Microbiology Conference on Candida and Candidiasis, San Diego, CA, 1996.
41. Chakir J, Cote L, Coulombe C, Deslauriers N. Differential pattern of infection and immune response during experimental oral candidiasis in BALB/c and DBA/2 (H-2d) mice. Oral Microbial Immunol 1994;9:88-94.
42. Sweet SP, Rahman D, Challacombe SJ. IgA subclasses in HIV disease: dichotomy between raised levels in serum and decreased secretion rates in saliva. Immunol 1995;86:556-9.
43. Cartry O, Moja P, Quesnel A, Pozzetto B, Lucht FR, Genin C. Quantification of IgA and IgG and specificities of antibodies to viral proteins in parotid saliva at different stages of HIV-1 infection. Clin Exp Immunol 1997;109:47-53.